(Total Views: 417)
Posted On: 10/23/2020 11:20:44 AM
Post# of 208
$TSOI has been very badly beaten down stock despite TSOI releasing about 15 stellar PRs since June 2020. One of the Key things that Prs stated was TSOI products QM and NS in particular can potentially prevent COVID-19 and Cancer respectively.
Many brought immediately and have made a killing trading this stock; trading it because no stock ever goes straight up short-term without a few corrections. Now we are in a holding pattern waiting on more news.
If the NEWS is good investors have the potential for a huge gain, far exceeding what any short could ever make. Thats all I got to say to the naysayers for now!
We know that the longs aren’t selling, but instead buying when MMs bring the SP down. Why? Because we expect to hear from TSOI within a couple of weeks there will be update on Quadramune FDA Phase II Clinical Trial.
Now that TSOI has spelt it out in its latest PR that it is seeking partnership(s) with public/private pharma, there will be no more foot dragging. Word will get out formally or otherwise. Then the real action shall begin.
TSOI already has enough data from its phase I trial with NanoStilbene and Quadramune... so we know it’s safe. We expect to see TSOI file NEW INDs for JADICELL... I’m not even taking into consideration the possible STEMVAC2 Phase I trial on COVID patients. I’m not a financial guru or scientist, but the PPS is only go up and up as its pretty easy to read for anyone who does their dd. You can bet the big guys have been slowly absorbing the sells at these levels.
Many brought immediately and have made a killing trading this stock; trading it because no stock ever goes straight up short-term without a few corrections. Now we are in a holding pattern waiting on more news.
If the NEWS is good investors have the potential for a huge gain, far exceeding what any short could ever make. Thats all I got to say to the naysayers for now!
We know that the longs aren’t selling, but instead buying when MMs bring the SP down. Why? Because we expect to hear from TSOI within a couple of weeks there will be update on Quadramune FDA Phase II Clinical Trial.
Now that TSOI has spelt it out in its latest PR that it is seeking partnership(s) with public/private pharma, there will be no more foot dragging. Word will get out formally or otherwise. Then the real action shall begin.
TSOI already has enough data from its phase I trial with NanoStilbene and Quadramune... so we know it’s safe. We expect to see TSOI file NEW INDs for JADICELL... I’m not even taking into consideration the possible STEMVAC2 Phase I trial on COVID patients. I’m not a financial guru or scientist, but the PPS is only go up and up as its pretty easy to read for anyone who does their dd. You can bet the big guys have been slowly absorbing the sells at these levels.
(0)
(0)Scroll down for more posts ▼
